Junto Capital Management’s Boston Scientific BSX Stock Holding History

Junto Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-168,254	Closed	-$17M	–	79
2025 Q1	$17M	Sell	168,254 -942,842	-85%	-$94.9M	0.36%	79
2024 Q4	$99.2M	Sell	1,111,096 -608,463	-35%	-$53.6M	1.92%	14
2024 Q3	$144M	Sell	1,719,559 -282,656	-14%	-$22.3M	3.19%	3
2024 Q2	$154M	Sell	2,002,215 -152,913	-7%	-$11.2M	3.16%	4
2024 Q1	$148M	Sell	2,155,128 -849,560	-28%	-$54.6M	3.27%	3
2023 Q4	$174M	Sell	3,004,688 -528,564	-15%	-$28.2M	3.88%	2
2023 Q3	$187M	Buy	3,533,252 +1,452,665	+70%	+$76.2M	4.42%	3
2023 Q2	$113M	Buy	2,080,587 +1,731,478	+496%	+$90.4M	2.85%	7
2023 Q1	$17.5M	Buy	+349,109	New	+$16.5M	0.48%	72

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Junto Capital Management's BSX Position: Q2 2025 in Review

Junto Capital Management sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 168,254 shares — an estimated $17M sold.

Junto Capital Management first reported a position in BSX in Q1 2023 and held it in 9 quarters. The position peaked at $187M in Q3 2023. 1,693 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

Junto Capital Management reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
Junto Capital Management sold 168,254 Boston Scientific shares in Q2 2025, an estimated $17M.
Junto Capital Management first reported a position in Boston Scientific in Q1 2023 and held it in 9 quarters.
Junto Capital Management's Boston Scientific position peaked at $187M in Q3 2023.
1,693 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Junto Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.